Reversible anorgasmia with topiramate for migraine prophylaxis

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 24, Issue 2, 2012, Pages

  Coebergh, Jan A ^a   Waldinger, Marcel D ^a,b  

^a HAGA HOSPITAL   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

METOPROLOL; ORAL CONTRACEPTIVE AGENT; RIZATRIPTAN; TOPIRAMATE;

ADULT; ANORGASMIA; CASE REPORT; DISEASE SEVERITY; FEMALE; HEADACHE; HUMAN; LETTER; MEDICAL HISTORY; MIGRAINE; MIGRAINE AURA; NAUSEA; PHONOPHOBIA; PHOTOPHOBIA; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROPHYLAXIS; TREATMENT DURATION; VOMITING;

EID: 84865114210     PISSN: 08950172     EISSN: 15457222     Source Type: Journal    
DOI: 10.1176/appi.neuropsych.11040081     Document Type: Letter

References (7)

1. Sexual Pharmacology: Fast Facts. Edited by Taylor R, Segraves, Balon R. New York, Norton, 2003
2. The International Classification of Headache Disorders, 2nd Edition. Cephalalgia 2004; 24:Suppl 1:9
3. Sun C, Lay C, Broner S, et al: Reversible anorgasmia with topiramate therapy for headache: a report of seven patients. Headache 2006; 46:1450-1453
4. Lasaosa SS, Fernández LG, del Val LJ: [Anorgasmia due to topiramate]. Neurologia 2008; 23:541-542
5. Holtkamp M, Weissinger F, Meierkord H: Erectile dysfunction with topiramate. Epilepsia 2005; 46: 166-167
6. Epstein RJ, Allen RC, Lunde MW: Organic impotence associated with carbonic anhydrase inhibitor therapy for glaucoma. Ann Ophthalmol 1987; 19:48-50 7.
7. Schiffer WK, Gerasimov MR, Marsteller DA, et al: Topiramate selectively attenuates nicotine-induced increases in monoamine release. Synapse 2001; 42:196-198